Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Prevalence, Clinical Severity, and Serotype Distribution of Pneumococcal Pneumonia Among Adults Hospitalized With Community-Acquired Pneumonia in Tennessee and Georgia, 2018-2022..
79:838-847.
2024
-
Performance of Urinalysis Parameters in Predicting Urinary Tract Infection: Does One Size Fit All?.
79:600-603.
2024
-
Pitavastatin is Well-Tolerated with no Detrimental Effects on Physical Function.
2024
-
Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time Series Analysis of 2016-2021 Data..
79:312-320.
2024
-
The Ethical Obligation to Treat Infectious Patients: A Systematic Review of Reasons..
79:339-347.
2024
-
Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study.
2024
-
Cefoxitin for Intra-amniotic Infections and Endometritis: A Retrospective Comparison to Traditional Antimicrobial Therapy Regimens Within a Healthcare System..
79:247-254.
2024
-
Unlinking Time Zero From Test-Negative Controls Exaggerates Risk From COVID-19..
79:273-274.
2024
-
Excellence in Antibiotic Stewardship: A Mixed-Methods Study Comparing High-, Medium-, and Low-Performing Hospitals..
78:1412-1424.
2024
-
Polypharmacy Is Associated With Slow Gait Speed and Recurrent Falls in Older People With HIV..
78:1608-1616.
2024
-
Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular Disease..
78:395-401.
2024
-
Infectious Inequity: How the Gut Microbiome and Social Determinants of Health May Contribute to Clostridioides difficile Infection Among Racial and Ethnic Minorities..
77:S455-S462.
2023
-
A Multicenter Retrospective Cohort Study to Characterize Patients Hospitalized With Multisystem Inflammatory Syndrome in Adults and Coronavirus Disease 2019 in the United States, 2020-2021..
77:1395-1405.
2023
-
Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections..
77:703-710.
2023
-
Body Composition Changes Over the Menopausal Transition in Women With and Without Human Immunodeficiency Virus..
77:265-271.
2023
-
Health Insurance and Initiation of Direct-Acting Antivirals for Hepatitis C in US Women With Human Immunodeficiency Virus..
77:258-264.
2023
-
Your Outpatient has Coronavirus Disease 2019: What Are the Treatment Options in the Current Severe Acute Respiratory Syndrome Coronavirus 2 Variant Climate?.
77:32-37.
2023
-
Cryptococcal Meningitis and Clinical Outcomes in Persons With Human Immunodeficiency Virus: A Global View..
76:2116-2125.
2023
-
Cytomegalovirus IgG Titer and Coronary Artery Disease in People with HIV..
76:e613-e621.
2023
-
Effect of Adopting the New Race-Free 2021 Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration Rate Creatinine Equation on Racial Differences in Kidney Disease Progression Among People With Human Immunodeficiency Virus: An Observational Study..
76:461-468.
2023
-
Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial..
76:e1-e9.
2023
-
Menopausal Hormone Therapy and Subclinical Cardiovascular Disease in Women With and Without Human Immunodeficiency Virus..
76:e661-e670.
2023
-
The Disproportionate Impact of COVID-19 Pandemic on Healthcare-Associated Infections in Community Hospitals: Need for Expanding the Infectious Disease Workforce..
76:e34-e41.
2023
-
Tuberculosis Treatment Outcomes in Brazil: Different Predictors for Each Type of Unsuccessful Outcome..
76:e930-e937.
2023
-
Human Immunodeficiency Virus and Cardiac End-Organ Damage in Women: Findings From an Echocardiographic Study Across the United States..
76:210-219.
2023
-
Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States..
76:323-334.
2023
-
Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections..
77:703-710.
2023
-
Rapid Environmental Contamination with Candida auris and Multidrug-Resistant Bacterial Pathogens Near Colonized Patients.
2023
-
Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy..
75:1324-1333.
2022
-
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk..
75:1154-1163.
2022
-
Discrimination And Calibration Of The Vacs Index 2.0 For Predicting Mortality Among People With Hiv In North America..
75:297-304.
2022
-
Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant..
75:e361-e367.
2022
-
Human Immunodeficiency Virus (HIV) and Menopause Are Independently Associated With Lower Bone Mineral Density: Results From the Women's Interagency HIV Study..
75:65-72.
2022
-
Factors Associated With Readmission in the United States Following Hospitalization With Coronavirus Disease 2019..
74:1713-1721.
2022
-
Evaluation of the Infectious Diseases Society of America's Core Antimicrobial Stewardship Curriculum for Infectious Diseases Fellows..
74:965-972.
2022
-
Strengths and Challenges of Various Models of Geriatric Consultation for Older Adults Living With Human Immunodeficiency Virus..
74:1101-1106.
2022
-
Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients: A Case Series and Review of the Literature..
74:479-489.
2022
-
Trends Over Time in the Risk of Adverse Outcomes Among Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection..
74:416-426.
2022
-
A Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes..
74:973-982.
2022
-
Enterococcus Intestinal Domination is Associated with Increased Mortality in the Acute Leukemia Chemotherapy Population..
78:414-22.
2021
-
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019..
73:e4197-e4205.
2021
-
Impact of Sex and Metabolic Comorbidities on Coronavirus Disease 2019 (COVID-19) Mortality Risk Across Age Groups: 66 646 Inpatients Across 613 U.S. Hospitals..
73:e4113-e4123.
2021
-
Higher Completion Rates With Self-administered Once-weekly Isoniazid-rifapentine Versus Daily Rifampin in Adults With Latent Tuberculosis..
73:e3459-e3467.
2021
-
Risk Factors for Testing Positive for Severe Acute Respiratory Syndrome Coronavirus 2 in a National United States Healthcare System..
73:e3085-e3094.
2021
-
Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials..
73:1440-1451.
2021
-
Breaking the Ambulatory Antibiotic Prescribing Cycle with All-Antibiotic Stewardship, Patient Stewardship, and Visit Stewardship..
73:e1680-e1683.
2021
-
CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018..
73:e2334-e2337.
2021
-
Investing in the Future: A Role for Professional Societies to Prepare the Next Generation of Healthcare Leaders Through Curriculum Development and Dissemination..
73:911-918.
2021
-
Baseline Neurocognitive Impairment (NCI) Is Associated With Incident Frailty but Baseline Frailty Does Not Predict Incident NCI in Older Persons With Human Immunodeficiency Virus (HIV)..
73:680-688.
2021
-
Survival Analysis of Treatment Efficacy in Comparative Coronavirus Disease 2019 Studies..
72:e887-e889.
2021
-
Reply to Rhoads, et al..
72:-.
2021
-
Striving to Reach the Optimal Measure for Catheter-Associated Urinary Tract Infection (CAUTI): Moving to Catheter Harm..
72:-.
2021
-
Antiretroviral Therapy Initiation Is Associated With Decreased Visceral and Subcutaneous Adipose Tissue Density in People Living With Human Immunodeficiency Virus..
72:979-986.
2021
-
Food Insecurity and T-cell Dysregulation in Women Living With Human Immunodeficiency Virus on Antiretroviral Therapy..
72:e112-e119.
2021
-
Optimizing Use of Antibiotics and Antivirals in Ambulatory Patients With Influenza..
72:574-575.
2021
-
Appropriateness of Antibiotic Prescribing for Acute Sinusitis in Primary Care: A Cross-sectional Study..
72:311-314.
2021
-
Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity..
72:301-308.
2021
-
Effects of National Adoption of Treat-All Guidelines on Pre-Antiretroviral Therapy (ART) CD4 Testing and Viral Load Monitoring After ART initiation: A Regression Discontinuity Analysis..
73:e1273-e1281.
2021
-
Reply to Evans et al..
71:2770-2771.
2020
-
Gut Microbiota Features on Nursing Home Admission Are Associated With Subsequent Acquisition of Antibiotic-resistant Organism Colonization..
71:3244-3247.
2020
-
Altered Gut Microbiota and Host Metabolite Profiles in Women With Human Immunodeficiency Virus..
71:2345-2353.
2020
-
Intersecting Epidemics: Incident Syphilis and Drug Use in Women Living With Human Immunodeficiency Virus in the United States (2005-2016)..
71:2405-2413.
2020
-
Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy..
71:e471-e477.
2020
-
The Effectiveness of Contact Precautions on Methicillin-Resistant Staphylococcus aureus in Long-term Care Across the United States..
71:1676-1683.
2020
-
Food Insecurity Is Associated With Lower Levels of Antiretroviral Drug Concentrations in Hair Among a Cohort of Women Living With Human Immunodeficiency Virus in the United States..
71:1517-1523.
2020
-
Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials..
71:1379-1389.
2020
-
Sex- and Poverty-Specific Patterns in Cardiovascular Disease Mortality Associated With Human Immunodeficiency Virus, New York City, 2007-2017..
71:491-498.
2020
-
Weight Gain Associated With Integrase Stand Transfer Inhibitor Use in Women..
71:593-600.
2020
-
Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy..
70:1267-1274.
2020
-
Differential Expression of Activation Markers by Mycobacterium tuberculosis-specific CD4+ T Cell Distinguishes Extrapulmonary From Pulmonary Tuberculosis and Latent Infection..
71:1905-1911.
2020
-
Increased Mortality After Tuberculosis Treatment Completion in Persons Living With Human Immunodeficiency Virus in Latin America..
71:215-217.
2020
-
Charting the Path Forward: Development, Goals and Initiatives of the 2019 Infectious Diseases Society of America Strategic Plan..
69:e1-e7.
2019
-
The Effects of Hepatitis C Treatment Eligibility Criteria on All-cause Mortality Among People With Human Immunodeficiency Virus..
69:1613-1620.
2019
-
Frailty Is an Independent Risk Factor for Mortality, Cardiovascular Disease, Bone Disease, and Diabetes Among Aging Adults With Human Immunodeficiency Virus..
69:1370-1376.
2019
-
Model-based Assessment of the Effect of Contact Precautions Applied to Surveillance-detected Carriers of Carbapenemase-producing Enterobacteriaceae in Long-term Acute Care Hospitals..
69:S206-S213.
2019
-
Understanding Workflow and Personal Protective Equipment Challenges Across Different Healthcare Personnel Roles..
69:S185-S191.
2019
-
Clostridioides (Formerly Clostridium) difficile Infection During Hospitalization Increases the Likelihood of Nonhome Patient Discharge..
68:1887-1893.
2019
-
Frailty, Neurocognitive Impairment, or Both in Predicting Poor Health Outcomes Among Adults Living With Human Immunodeficiency Virus..
68:131-138.
2019
-
Polymorphisms in TLR4 and TNFA and Risk of Mycobacterium tuberculosis Infection and Development of Active Disease in Contacts of Tuberculosis Cases in Brazil: A Prospective Cohort Study..
69:1027-1035.
2019
-
Antimicrobial Stewardship Training for Infectious Diseases Fellows: Program Directors Identify a Curriculum Need..
67:1285-1287.
2018
-
Longitudinal Assessment of Multidrug-Resistant Organisms in Newly Admitted Nursing Facility Patients: Implications for an Evolving Population..
67:837-844.
2018
-
The Role of Mitochondrial DNA Variation in Age-Related Decline in Gait Speed Among Older Men Living With Human Immunodeficiency Virus..
67:778-784.
2018
-
Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs..
66:893-903.
2018
-
The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection..
65:2042-2049.
2017
-
Implementing Antimicrobial Stewardship in Long-term Care Settings: An Integrative Review Using a Human Factors Approach..
65:1943-1951.
2017
-
Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study..
65:1316-1326.
2017
-
Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study..
65:100-106.
2017
-
Disability Among Middle-Aged and Older Persons With Human Immunodeficiency Virus Infection..
65:83-91.
2017
-
Infection Prevention Practices in Japan, Thailand, and the United States: Results From National Surveys..
64:S105-S111.
2017
-
Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection..
64:1422-1429.
2017
-
HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers..
64:468-475.
2017
-
Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression..
63:1661-1667.
2016
-
Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial..
63:999-1006.
2016
-
The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study..
63:694-702.
2016
-
Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia..
63:1-9.
2016
-
Rosuvastatin Worsens Insulin Resistance in HIV-Infected Adults on Antiretroviral Therapy..
61:1566-72.
2015
-
Impact of Hospital Population Case-Mix, Including Poverty, on Hospital All-Cause and Infection-Related 30-Day Readmission Rates..
61:1235-43.
2015
-
HIV Infection Is Associated With Progression of Subclinical Carotid Atherosclerosis..
61:640-50.
2015
-
Enhancing Resident Safety by Preventing Healthcare-Associated Infection: A National Initiative to Reduce Catheter-Associated Urinary Tract Infections in Nursing Homes..
61:86-94.
2015
-
Reply to Haddow et al..
60:1442-3.
2015
-
RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration..
61Suppl 3:S155-9.
2015
-
Editorial commentary: Preventing aspiration pneumonia in high-risk nursing home residents: role of chlorhexidine-based oral care questioned again..
60:858-9.
2014
-
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study..
60:473-80.
2014
-
The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status..
60:646-52.
2014
-
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America..
59:e96-138.
2014
-
Reply to Sachdev et al..
58:-.
2014
-
Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients..
58:997-1002.
2013
-
A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy..
58:883-90.
2013
-
Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada..
58:704-12.
2013
-
Infection prevention in the cancer center..
57:579-85.
2013
-
Urinary tract infections: current and emerging management strategies..
57:719-24.
2013
-
Traditional chinese medicine: an alternative treatment option for refractory recurrent urinary tract infections..
56:-.
2013
-
Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease..
54:408-13.
2011
-
Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy..
52:1267-75.
2011
-
Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit..
52:1108-1115.
2011
-
Conceptual model for reducing infections and antimicrobial resistance in skilled nursing facilities: focusing on residents with indwelling devices..
52:654-61.
2011
-
Coexistence of blaNDM-1 with the prevalent blaOXA23 and blaIMP in pan-drug resistant Acinetobacter baumannii isolates in China..
52:692-3.
2011
-
Immunosenescence and vaccination in nursing home residents..
48:443-8.
2009
-
Editorial commentary: antibiotics for treatment of acute respiratory tract infections: decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance..
47:744-6.
2008
-
Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin..
47:56-62.
2008
-
Secondary syphilis with ocular manifestations in older adults..
46:e142-5.
2008
-
Epidemiology of Staphylococcus aureus colonization in nursing home residents..
46:1368-73.
2008
-
Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy..
46:305-12.
2008
-
Preventing hospital-acquired urinary tract infection in the United States: a national study..
46:243-50.
2008
-
Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia..
46:30-6.
2008
-
Improving care for acute respiratory infections: better systems, not better microbiology..
45:1189-91.
2007
-
Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents..
45:992-8.
2007
-
Suburban leptospirosis: atypical lymphocytosis and gamma-delta T cell response..
43:1304-7.
2006
-
Influenza deaths in spite of immunization and prophylaxis..
40:492-3.
2005
-
Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial..
37:1467-74.
2003
-
Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients..
34:340-5.
2001
-
Measuring the economic costs of antimicrobial resistance in hospital settings: summary of the Centers for Disease Control and Prevention-Emory Workshop..
33:1573-8.
2001
-
Photo quiz. Pulmonary tuberculosis..
27:1137, 1318-9.
1998
-
Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia..
25:1056-9.
1997
-
Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years..
24:514-5.
1997
-
The Ethical Obligation to Treat Infectious Patients: A Systematic Review of Reasons
2024
-
Bedbugs and Vector-Borne Diseases
2014
-
Bedbugs and vector-borne diseases
2014
-
Bedbugs and vector-borne diseases
2014
-
Bedbugs and vector-borne diseases
2014
-
Psychotropic Medications and HIV
2006
Identity
International Standard Serial Number (ISSN)
-
1058-4838
-
1537-6591
-
15376591 10584838